International Stem Cell (OTCMKTS:ISCO) Shares Pass Above Two Hundred Day Moving Average – Here’s Why

Shares of International Stem Cell Corp. (OTCMKTS:ISCO) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.16 and traded as high as $0.1725. International Stem Cell shares last traded at $0.1725, with a volume of 597 shares trading hands.

International Stem Cell Stock Performance

The company has a 50 day moving average of $0.18 and a 200-day moving average of $0.16. The stock has a market cap of $2.51 million, a price-to-earnings ratio of -5.23 and a beta of -0.01.

International Stem Cell (OTCMKTS:ISCO) last released its earnings results on Thursday, May 14th. The biotechnology company reported ($0.03) earnings per share for the quarter. The business had revenue of $2.32 million during the quarter.

About International Stem Cell

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.